136 related articles for article (PubMed ID: 26004269)
1. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection.
Chhibber T; Wadhwa S; Chadha P; Sharma G; Katare OP
J Drug Target; 2015 Dec; 23(10):943-52. PubMed ID: 26004269
[TBL] [Abstract][Full Text] [Related]
2. Nano-engineered lipid-polymer hybrid nanoparticles of fusidic acid: an investigative study on dermatokinetics profile and MRSA-infected burn wound model.
Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
Drug Deliv Transl Res; 2019 Aug; 9(4):748-763. PubMed ID: 30652257
[TBL] [Abstract][Full Text] [Related]
3. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Chhibber T; Gondil VS; Sinha VR
AAPS PharmSciTech; 2020 Jan; 21(2):43. PubMed ID: 31897806
[TBL] [Abstract][Full Text] [Related]
4. Cationic-bilayered nanoemulsion of fusidic acid: an investigation on eradication of methicillin-resistant Staphylococcus aureus 33591 infection in burn wound.
Thakur K; Sharma G; Singh B; Jain A; Tyagi R; Chhibber S; Katare OP
Nanomedicine (Lond); 2018 Apr; 13(8):825-847. PubMed ID: 29528278
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus.
Gharib A; Faezizadeh Z; Godarzee M
Skin Pharmacol Physiol; 2013; 26(2):68-75. PubMed ID: 23296023
[TBL] [Abstract][Full Text] [Related]
6. Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria.
Dolgachev VA; Ciotti SM; Eisma R; Gracon S; Wilkinson JE; Baker JR; Hemmila MR
J Burn Care Res; 2016; 37(2):e104-14. PubMed ID: 26182074
[TBL] [Abstract][Full Text] [Related]
7. The role of nasal carriage in Staphylococcus aureus burn wound colonization.
Kooistra-Smid M; Nieuwenhuis M; van Belkum A; Verbrugh H
FEMS Immunol Med Microbiol; 2009 Oct; 57(1):1-13. PubMed ID: 19486150
[TBL] [Abstract][Full Text] [Related]
8. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies.
Raza K; Negi P; Takyar S; Shukla A; Amarji B; Katare OP
J Microencapsul; 2011; 28(3):190-9. PubMed ID: 21395406
[TBL] [Abstract][Full Text] [Related]
9. Effective Topical Delivery of H-AgNPs for Eradication of Klebsiella pneumoniae-Induced Burn Wound Infection.
Chhibber S; Gondil VS; Singla L; Kumar M; Chhibber T; Sharma G; Sharma RK; Wangoo N; Katare OP
AAPS PharmSciTech; 2019 Apr; 20(5):169. PubMed ID: 31004249
[TBL] [Abstract][Full Text] [Related]
10. Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
Chopra S; Harjai K; Chhibber S
Int J Med Microbiol; 2016 Dec; 306(8):707-716. PubMed ID: 27616281
[TBL] [Abstract][Full Text] [Related]
11. Determining the effect of an oak bark formulation on methicillin-resistant staphylococcus aureus and wound healing in porcine wound models.
Davis SC; Mertz PM
Ostomy Wound Manage; 2008 Oct; 54(10):16-8, 20, 22-5. PubMed ID: 18927480
[TBL] [Abstract][Full Text] [Related]
12. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
Cui F; Li G; Huang J; Zhang J; Lu M; Lu W; Huan J; Huang Q
Drug Deliv; 2011 Apr; 18(3):173-80. PubMed ID: 20726806
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of burn wound healing activity of novel fusidic acid loaded microemulsion based gel in male Wistar albino rats.
Okur ME; Ayla Ş; Yozgatlı V; Aksu NB; Yoltaş A; Orak D; Sipahi H; Üstündağ Okur N
Saudi Pharm J; 2020 Mar; 28(3):338-348. PubMed ID: 32194336
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice.
Jaspers ME; Breederveld RS; Tuinebreijer WE; Diederen BM
Burns; 2014 Dec; 40(8):1570-4. PubMed ID: 24685351
[TBL] [Abstract][Full Text] [Related]
15. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
Bharti SK; Kesavan K
Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
[TBL] [Abstract][Full Text] [Related]
16. [Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice].
Huan JN
Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):270-1, 316. PubMed ID: 1289000
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.
Simonetti O; Cirioni O; Lucarini G; Orlando F; Ghiselli R; Silvestri C; Brescini L; Rocchi M; Provinciali M; Guerrieri M; Di Primio R; Giacometti A; Offidani A
J Antimicrob Chemother; 2012 Jan; 67(1):191-201. PubMed ID: 22065244
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-oxacillin resistant strains of Staphylococcus aureus (MORSA) in infected burn wounds.
Polaczek-Kornecka B; Dziadur-Goldsztaj Z; Turowski G
Mater Med Pol; 1991; 23(4):304-5. PubMed ID: 1842238
[TBL] [Abstract][Full Text] [Related]
19. Chitosan and phospholipid assisted topical fusidic acid drug delivery in burn wound: Strategies to conquer pharmaceutical and clinical challenges, opportunities and future panorama.
Jyoti K; Malik G; Chaudhary M; Sharma M; Goswami M; Katare OP; Singh SB; Madan J
Int J Biol Macromol; 2020 Oct; 161():325-335. PubMed ID: 32485249
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for acquisition of Methicillin-resistant Staphylococcus aureus among patients from a burn unit in Brazil.
Toscano Olivo TE; de Melo EC; Rocha C; Fortaleza CM
Burns; 2009 Dec; 35(8):1104-11. PubMed ID: 19481351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
